Coeptis Therapeutics Holdings, Inc. announced on July 22, 2025, the extinguishment of its convertible note with YA II PN, Ltd ("Yorkville"). This action cleared the company’s outstanding debt obligations to Yorkville, specifically the convertible note dated January 16, 2025. This move strengthens the company's capital structure.
David Mehalick, CEO of Coeptis Therapeutics Holdings, Inc., stated that the extinguishment of these outstanding debt obligations positions the company well to pursue its long-term goals. He noted that a streamlined capital structure, free from unnecessary outstanding obligations, will help the company navigate its proposed strategic addition of operations in the cryptocurrency space.
This financial maneuver improves Coeptis' balance sheet by reducing its debt burden. It provides greater financial flexibility as the company continues its strategic pivot towards technology and digital asset mining. The elimination of this convertible note is a positive development for the company's financial health.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.